BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34498133)

  • 1. Concurrent use of statins and neoadjuvant chemoradiotherapy for rectal cancer: a systematic review and meta-analysis.
    McKechnie T; Talwar G; Lee Y; Levine O; Eskicioglu C
    Int J Colorectal Dis; 2021 Dec; 36(12):2715-2727. PubMed ID: 34498133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statin therapy is associated with improved pathologic response to neoadjuvant chemoradiation in rectal cancer.
    Mace AG; Gantt GA; Skacel M; Pai R; Hammel JP; Kalady MF
    Dis Colon Rectum; 2013 Nov; 56(11):1217-27. PubMed ID: 24104995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Statin Use and Oncological Outcomes After Neoadjuvant Radiotherapy in Patients With Rectal Cancer.
    Fransgaard T; Hallas J; Thygesen LC; Gögenur I
    Anticancer Res; 2019 Apr; 39(4):2177-2182. PubMed ID: 30952765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of statin use with a pathologic complete response to neoadjuvant chemoradiation for rectal cancer.
    Katz MS; Minsky BD; Saltz LB; Riedel E; Chessin DB; Guillem JG
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1363-70. PubMed ID: 16029794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent Use of Statins in Patients Undergoing Curative Intent Treatment for Triple Negative Breast Cancer: A Systematic Review and Meta-Analysis.
    McKechnie T; Brown Z; Lovrics O; Yang S; Kazi T; Eskicioglu C; Parvez E
    Clin Breast Cancer; 2024 Apr; 24(3):e103-e115. PubMed ID: 38296737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of statin and aspirin use on toxicity and pathological complete response rate of neo-adjuvant chemoradiation for rectal cancer.
    Hardie C; Jung Y; Jameson M
    Asia Pac J Clin Oncol; 2016 Jun; 12(2):167-73. PubMed ID: 26947944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of Pathologic Complete Response After Neoadjuvant Treatment for Rectal Cancer: A Multicenter Study.
    Armstrong D; Raissouni S; Price Hiller J; Mercer J; Powell E; MacLean A; Jiang M; Doll C; Goodwin R; Batuyong E; Zhou K; Monzon JG; Tang PA; Heng DY; Cheung WY; Vickers MM
    Clin Colorectal Cancer; 2015 Dec; 14(4):291-5. PubMed ID: 26433487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival Benefit for Metformin Through Better Tumor Response by Neoadjuvant Concurrent Chemoradiotherapy in Rectal Cancer.
    Kim JM; Park JW; Lee JH; Park YH; Park SJ; Cheon JH; Kim WH; Kim TI
    Dis Colon Rectum; 2020 Jun; 63(6):758-768. PubMed ID: 32384406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aspirin use on neoadjuvant chemoradiotherapy for rectal cancer: a meta-analysis with trial sequential analysis.
    Wang B; Huang Y
    J Cancer Res Clin Oncol; 2020 Aug; 146(8):2161-2171. PubMed ID: 32328776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
    Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
    [No Abstract]   [Full Text] [Related]  

  • 11. Statins increase pathological response in locally advanced rectal cancer treated with chemoradiation: a multicenter experience.
    Caputo F; Santini C; Casadei-Gardini A; Cerma K; Bardasi C; GarajovĂ  I; Lattanzi E; Passardi A; Rapposelli IG; Spallanzani A; Salati M; Bonetti LR; Gelmini R; Meduri B; Piccoli M; Pecchi A; Benatti S; Piacentini F; Dominici M; Luppi G; Gelsomino F
    Future Oncol; 2022 Aug; 18(24):2651-2659. PubMed ID: 35791815
    [No Abstract]   [Full Text] [Related]  

  • 12. Timing of surgery after long-course neoadjuvant chemoradiotherapy for rectal cancer: a systematic review of the literature.
    Foster JD; Jones EL; Falk S; Cooper EJ; Francis NK
    Dis Colon Rectum; 2013 Jul; 56(7):921-30. PubMed ID: 23739201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
    Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of interval between neoadjuvant chemoradiotherapy and surgery in rectal cancer patients.
    Mei SW; Liu Z; Wei FZ; Chen JN; Wang ZJ; Shen HY; Li J; Zhao FQ; Pei W; Wang Z; Wang XS; Liu Q
    World J Gastroenterol; 2020 Aug; 26(31):4624-4638. PubMed ID: 32884221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxaliplatin/fluorouracil-based adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery: a systematic review and meta-analysis of randomized controlled trials.
    Zhao L; Liu R; Zhang Z; Li T; Li F; Liu H; Li G
    Colorectal Dis; 2016 Aug; 18(8):763-72. PubMed ID: 27169752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).
    Kim CW; Kang BM; Kim IY; Kim JY; Park SJ; Park WC; Bae KB; Bae BN; Baek SK; Baik SH; Son GM; Lee YS; Lee SH
    BMC Cancer; 2018 May; 18(1):538. PubMed ID: 29739356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated platelet count is a negative predictive and prognostic marker in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: a retrospective multi-institutional study on 965 patients.
    Belluco C; Forlin M; Delrio P; Rega D; Degiuli M; Sofia S; Olivieri M; Pucciarelli S; Zuin M; De Manzoni G; Di Leo A; Scabini S; Zorcolo L; Restivo A
    BMC Cancer; 2018 Nov; 18(1):1094. PubMed ID: 30419864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of nodal disease in patients with pathological complete responses after neoadjuvant chemoradiation for rectal cancer: a systematic review, meta-analysis, and meta-regression.
    Wee IJY; Cao HM; Ngu JC
    Int J Colorectal Dis; 2019 Aug; 34(8):1349-1357. PubMed ID: 31273449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wait and see approach for rectal cancer with a clinically complete response after neoadjuvant concurrent chemoradiotherapy.
    Kim HJ; Song JH; Ahn HS; Choi BH; Jeong H; Choi HS; Lee YH; Kang KM; Jeong BK
    Int J Colorectal Dis; 2017 May; 32(5):723-727. PubMed ID: 27885479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    Lin H; Wang L; Zhong X; Zhang X; Shao L; Wu J
    World J Surg Oncol; 2021 May; 19(1):141. PubMed ID: 33952287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.